BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 18499708)

  • 1. Follicle dynamics and anovulation in polycystic ovary syndrome.
    Franks S; Stark J; Hardy K
    Hum Reprod Update; 2008; 14(4):367-78. PubMed ID: 18499708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant follicle development and anovulation in polycystic ovary syndrome.
    Franks S; Hardy K
    Ann Endocrinol (Paris); 2010 May; 71(3):228-30. PubMed ID: 20362969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone and polycystic ovary syndrome.
    Bhide P; Homburg R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
    Jonard S; Dewailly D
    Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
    Das M; Gillott DJ; Saridogan E; Djahanbakhch O
    Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular dynamics in the polycystic ovary syndrome.
    Franks S; Mason H; Willis D
    Mol Cell Endocrinol; 2000 May; 163(1-2):49-52. PubMed ID: 10963873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polycystic ovary syndrome: A model of follicular excess].
    Robin G; Catteau-Jonard S; Dewailly D; Decanter C
    Gynecol Obstet Fertil; 2010 Jun; 38(6):405-8. PubMed ID: 20576552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome.
    van der Spuy ZM; Dyer SJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):755-71. PubMed ID: 15380145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic ovary syndrome].
    Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of AMH in anovulation associated with PCOS: a hypothesis.
    Homburg R; Crawford G
    Hum Reprod; 2014 Jun; 29(6):1117-21. PubMed ID: 24770999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-Mullerian hormone and polycystic ovary syndrome].
    Catteau-Jonard S; Dewailly D
    Gynecol Obstet Fertil; 2011 Sep; 39(9):514-7. PubMed ID: 21840745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.
    Fleming R; Deshpande N; Traynor I; Yates RW
    Hum Reprod; 2006 Jun; 21(6):1436-41. PubMed ID: 16439501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disordered follicle development in ovaries of prenatally androgenized ewes.
    Forsdike RA; Hardy K; Bull L; Stark J; Webber LJ; Stubbs S; Robinson JE; Franks S
    J Endocrinol; 2007 Feb; 192(2):421-8. PubMed ID: 17283242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
    Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone and ovarian dysfunction.
    Broekmans FJ; Visser JA; Laven JS; Broer SL; Themmen AP; Fauser BC
    Trends Endocrinol Metab; 2008 Nov; 19(9):340-7. PubMed ID: 18805020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
    Stubbs SA; Hardy K; Da Silva-Buttkus P; Stark J; Webber LJ; Flanagan AM; Themmen AP; Visser JA; Groome NP; Franks S
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation.
    Willis DS; Watson H; Mason HD; Galea R; Brincat M; Franks S
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3984-91. PubMed ID: 9814480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.